AU6281599A - Alternate day administration of copolymer 1 for treating autoimmune diseases - Google Patents
Alternate day administration of copolymer 1 for treating autoimmune diseasesInfo
- Publication number
- AU6281599A AU6281599A AU62815/99A AU6281599A AU6281599A AU 6281599 A AU6281599 A AU 6281599A AU 62815/99 A AU62815/99 A AU 62815/99A AU 6281599 A AU6281599 A AU 6281599A AU 6281599 A AU6281599 A AU 6281599A
- Authority
- AU
- Australia
- Prior art keywords
- copolymer
- autoimmune diseases
- treating autoimmune
- day administration
- alternate day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10296198P | 1998-10-02 | 1998-10-02 | |
| US60102961 | 1998-10-02 | ||
| PCT/US1999/022836 WO2000020010A1 (en) | 1998-10-02 | 1999-10-01 | Alternate day administration of copolymer 1 for treating autoimmune diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6281599A true AU6281599A (en) | 2000-04-26 |
Family
ID=22292624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU62815/99A Abandoned AU6281599A (en) | 1998-10-02 | 1999-10-01 | Alternate day administration of copolymer 1 for treating autoimmune diseases |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU6281599A (en) |
| WO (1) | WO2000020010A1 (en) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2527760T3 (en) | 1998-07-23 | 2015-01-29 | Yeda Research And Development Co., Ltd. | Treatment of Crohn's disease with copolymer 1 and polypeptides |
| WO2000005250A1 (en) | 1998-07-23 | 2000-02-03 | Yeda Research And Development Co., Ltd | Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| US6800287B2 (en) | 1998-09-25 | 2004-10-05 | Yeda Research And Development Co., Ltd. | Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| ZA200206457B (en) | 2000-02-18 | 2003-08-13 | Yeda Res & Dev | Oral, nasal and pulmonary dosage formulations of copolymer 1. |
| JP2003522799A (en) * | 2000-02-18 | 2003-07-29 | イエダ・リサーチ・アンド・ディベロップメント・カンパニー・リミテッド・アット・ザ・ウェイズマン・インスティテュート・オブ・サイエンス | Oral, Nasal and Pulmonary Formulations of Copolymer 1 |
| US20020077278A1 (en) | 2000-06-05 | 2002-06-20 | Yong V. Wee | Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders |
| WO2002076503A1 (en) | 2000-06-20 | 2002-10-03 | Mayo Foundation For Medical Education And Research | Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| SI1459065T1 (en) | 2001-12-04 | 2010-11-30 | Teva Pharma | Processes for the measurement of the potency of glatiramer acetate |
| PT1592384E (en) * | 2003-01-21 | 2013-01-28 | Yeda Res & Dev | Cop 1 for treatment of inflammatory bowel diseases |
| US20070197424A1 (en) * | 2003-09-16 | 2007-08-23 | Friedman Scott L | Glatiramer acetate for use as an immuno-modulatory agent |
| US7655221B2 (en) | 2004-05-07 | 2010-02-02 | Peptimmune, Inc. | Methods of treating disease with random copolymers |
| NZ598661A (en) | 2009-08-20 | 2013-02-22 | Yeda Res & Dev | Low frequency glatiramer acetate therapy |
| USRE49251E1 (en) | 2010-01-04 | 2022-10-18 | Mapi Pharma Ltd. | Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |
| AU2011313842B2 (en) | 2010-10-11 | 2016-12-15 | Teva Pharmaceutical Industries Ltd. | Cytokine biomarkers as predictive biomarkers of clinical response for glatiramer acetate |
| CA2851510A1 (en) | 2011-10-10 | 2013-04-18 | Teva Pharmaceutical Industries Ltd. | Single nucleotide polymorphisms useful to predict clinical response for glatiramer acetate |
| WO2014058976A2 (en) | 2012-10-10 | 2014-04-17 | Teva Pharmaceutical Industries Ltd. | Biomarkers predictive for clinical response for glatiramer acetate |
| UY35790A (en) | 2013-10-21 | 2015-05-29 | Teva Pharma | GENETIC MARKERS THAT PREACH THE RESPONSE TO THE GLATIRAMER ACETATE |
| US9155775B1 (en) | 2015-01-28 | 2015-10-13 | Teva Pharmaceutical Industries, Ltd. | Process for manufacturing glatiramer acetate product |
| US12097292B2 (en) | 2016-08-28 | 2024-09-24 | Mapi Pharma Ltd. | Process for preparing microparticles containing glatiramer acetate |
| WO2018178973A1 (en) | 2017-03-26 | 2018-10-04 | Mapi Pharma Ltd. | Glatiramer depot systems for treating progressive forms of multiple sclerosis |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5668117A (en) * | 1991-02-22 | 1997-09-16 | Shapiro; Howard K. | Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments |
| IL113812A (en) * | 1994-05-24 | 2000-06-29 | Yeda Res & Dev | Copolymer-1 pharmaceutical compositions containing it and its use |
-
1999
- 1999-10-01 AU AU62815/99A patent/AU6281599A/en not_active Abandoned
- 1999-10-01 WO PCT/US1999/022836 patent/WO2000020010A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000020010A1 (en) | 2000-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU6281599A (en) | Alternate day administration of copolymer 1 for treating autoimmune diseases | |
| AU698509B2 (en) | Compositions for the treatment of rheumatoid-based arthritic diseases | |
| AU2053597A (en) | Pharmaceutical compositions for the treatment of glaucoma | |
| AU7070596A (en) | Transdermal administration of olanzapine | |
| AU5095196A (en) | Medical implants | |
| AU4078997A (en) | Cholinesterase inhibitors for treatment of parkinson's disease | |
| AUPN411195A0 (en) | Medicinal composition | |
| AU1450900A (en) | Methods of treatment of type 2 diabetes | |
| AU2327599A (en) | Compositions and methods for treating autoimmune diseases | |
| AU7590096A (en) | Drug composition | |
| AU5605398A (en) | Novel methods and compositions for treatment of autoimmune diseases | |
| AU6590896A (en) | Pharmaceutical compositions containing tsg-6 for treating inflammatory diseases and cancer-related pathologies and methods | |
| AU9395998A (en) | Compositions and methods for the treatment of immune related diseases | |
| HUP9901303A3 (en) | A pharmaceutical composition for the treatment of autoimmune diseases | |
| GB9700737D0 (en) | Administration of drugs | |
| AU6369396A (en) | Drug for ameliorating brain diseases | |
| AU5526196A (en) | Compositions for the treatment of dandruff | |
| AU6517398A (en) | Therapeutic agent for autoimmune diseases | |
| AU1228499A (en) | Application of tnf antagonists as medicaments for treating septic diseases | |
| AU5699396A (en) | Compositions for the treatment of skin conditions | |
| AUPN727595A0 (en) | Therapeutic compositions | |
| AU8883998A (en) | Pharmaceutical compositions for the treatment of ocular inflammations comprisingdexamethasone palmitate | |
| AU5494298A (en) | Pharmaceutical compositions for the treatment of the eye | |
| AUPN542395A0 (en) | Macca's magic sinkers | |
| AU5296799A (en) | Pharmaceutical compositions against autoimmune diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |